For Journalists

Diamond, its scientists, and its world-leading facilities are helping to lead the charge against COVID-19 in many ways. Here you will find our latest news updates, as well as key information on resources, interview opportunities and press relations contacts.

Scientific research on the new SARS-CoV-2 virus (that causes the disease COVID-19) is a global priority and we are doing everything we can to help advance work on SARS-CoV-2 as a drug target, and on other proteins that represent potential weak points of the virus. 

To facilitate the fastest possible dissemination of research at this critical time, we are not following the usual research pathway of waiting for the publication of papers about this research in peer-reviewed journals before releasing data. We are making results available and sharing information as early and as rapidly as possible to help inform the scientific community and wider public.

The level of automation offered at our synchrotron has opened up ultra-high throughput screening methods, like the XChem fragment screening, which means that many samples can be analysed in great detail in a short amount of time.

Find out more information about our ongoing research on COVID-19, along with the most recent updates, here.